• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖化血红蛋白水平与未来糖尿病风险:系统综述。

A1C level and future risk of diabetes: a systematic review.

机构信息

Division of Diabetes Translation, National Center for Chronic Disease Prevention and HealthPromotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Xuanping Zhang,

出版信息

Diabetes Care. 2010 Jul;33(7):1665-73. doi: 10.2337/dc09-1939.

DOI:10.2337/dc09-1939
PMID:20587727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2890379/
Abstract

We examined ranges of A1C useful for identifying persons at high risk for diabetes prior to preventive intervention by conducting a systematic review. From 16 included studies, we found that annualized diabetes incidence ranged from 0.1% at A1C <5.0% to 54.1% at A1C >or=6.1%. Findings from 7 studies that examined incident diabetes across a broad range of A1C categories showed 1) risk of incident diabetes increased steeply with A1C across the range of 5.0 to 6.5%; 2) the A1C range of 6.0 to 6.5% was associated with a highly increased risk of incident diabetes, 25 to 50% incidence over 5 years; 3) the A1C range of 5.5 to 6.0% was associated with a moderately increased relative risk, 9 to 25% incidence over 5 years; and 4) the A1C range of 5.0 to 5.5% was associated with an increased incidence relative to those with A1C <5%, but the absolute incidence of diabetes was less than 9% over 5 years. Our systematic review demonstrated that A1C values between 5.5 and 6.5% were associated with a substantially increased risk for developing diabetes.

摘要

我们通过系统回顾来研究 A1C 范围,以确定在进行预防性干预之前哪些人具有患糖尿病的高风险。在纳入的 16 项研究中,我们发现糖化血红蛋白(A1C)<5.0%时,糖尿病年发生率为 0.1%,而 A1C≥6.1%时则高达 54.1%。7 项研究对 A1C 广泛范围内的新发糖尿病进行了检测,结果显示:1)A1C 范围内 5.0 至 6.5%之间,风险随着 A1C 的增加而急剧增加;2)A1C 范围在 6.0 至 6.5%之间与发生糖尿病的风险高度增加相关,5 年内的发病率为 25%至 50%;3)A1C 范围在 5.5 至 6.0%之间与相对风险中度增加相关,5 年内的发病率为 9%至 25%;4)A1C 范围在 5.0 至 5.5%之间与 A1C<5%的人相比,发生糖尿病的风险增加,但 5 年内糖尿病的绝对发病率低于 9%。我们的系统回顾表明,A1C 值在 5.5%至 6.5%之间与发生糖尿病的风险显著增加有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572b/2890379/cf7eaf425499/zdc0071083210002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572b/2890379/59bcf45716f5/zdc0071083210001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572b/2890379/cf7eaf425499/zdc0071083210002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572b/2890379/59bcf45716f5/zdc0071083210001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/572b/2890379/cf7eaf425499/zdc0071083210002.jpg

相似文献

1
A1C level and future risk of diabetes: a systematic review.糖化血红蛋白水平与未来糖尿病风险:系统综述。
Diabetes Care. 2010 Jul;33(7):1665-73. doi: 10.2337/dc09-1939.
2
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.二肽基肽酶(DPP)-4抑制剂和胰高血糖素样肽(GLP)-1类似物用于预防或延缓2型糖尿病高危人群发生2型糖尿病及其相关并发症。
Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204. doi: 10.1002/14651858.CD012204.pub2.
3
Treatment of periodontitis for glycaemic control in people with diabetes mellitus.糖尿病患者牙周炎治疗与血糖控制。
Cochrane Database Syst Rev. 2022 Apr 14;4(4):CD004714. doi: 10.1002/14651858.CD004714.pub4.
4
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
8
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.胰岛素促泌剂用于预防或延缓2型糖尿病高危人群发生2型糖尿病及其相关并发症。
Cochrane Database Syst Rev. 2016 Oct 17;10(10):CD012151. doi: 10.1002/14651858.CD012151.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.

引用本文的文献

1
Prediabetes.糖尿病前期
Nat Rev Dis Primers. 2025 Jul 17;11(1):49. doi: 10.1038/s41572-025-00635-0.
2
Triglyceride-glycated hemoglobin index as a superior predictor of type 2 diabetes risk in a large-scale retrospective cohort study.在一项大规模回顾性队列研究中,甘油三酯糖化血红蛋白指数作为2型糖尿病风险的 superior 预测指标 。 注:原文中“superior”在这里直接保留英文,因为在医学语境中可能有特定含义未明确翻译,若要准确翻译需结合更多背景信息,这里按要求不添加解释直接保留。
Sci Rep. 2025 Jul 1;15(1):20898. doi: 10.1038/s41598-025-05786-4.
3
Machine learning-based prediction of diabetic peripheral neuropathy: model development and clinical validation.

本文引用的文献

1
Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.基于Inter99队列的一组血清生物标志物开发2型糖尿病风险模型。
Diabetes Care. 2009 Jul;32(7):1207-12. doi: 10.2337/dc08-1935.
2
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.国际专家委员会关于糖化血红蛋白检测在糖尿病诊断中作用的报告。
Diabetes Care. 2009 Jul;32(7):1327-34. doi: 10.2337/dc09-9033. Epub 2009 Jun 5.
3
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.
基于机器学习的糖尿病周围神经病变预测:模型开发与临床验证
Front Endocrinol (Lausanne). 2025 Jun 5;16:1614657. doi: 10.3389/fendo.2025.1614657. eCollection 2025.
4
Identification of pre-diabetes subphenotypes for type 2 diabetes, related vascular complications and mortality.2型糖尿病、相关血管并发症及死亡率的糖尿病前期亚表型识别。
BMJ Open Diabetes Res Care. 2025 Jun 9;13(3):e004803. doi: 10.1136/bmjdrc-2024-004803.
5
3D Mitochondrial Structure in Aging Human Skeletal Muscle: Insights Into MFN-2-Mediated Changes.衰老人类骨骼肌中的三维线粒体结构:对MFN-2介导变化的见解
Aging Cell. 2025 Apr 25:e70054. doi: 10.1111/acel.70054.
6
Visit-Based, EHR-Driven Clinical Decision Support to Identify Abnormal Glycemic Results and Promote Diabetes Screening: A Pragmatic Trial.基于就诊、电子健康记录驱动的临床决策支持以识别血糖异常结果并促进糖尿病筛查:一项实用性试验。
J Gen Intern Med. 2025 Apr 25. doi: 10.1007/s11606-025-09543-1.
7
Cardio-metabolic health and sleep quality in adults at risk for Type 2 Diabetes using the Fos Biomedical Non-Transdermal Patch System via photo-biomodulation: A randomized, placebo-controlled crossover trial.使用Fos生物医学非透皮贴剂系统通过光生物调节改善2型糖尿病高危成年人的心脏代谢健康和睡眠质量:一项随机、安慰剂对照的交叉试验。
Contemp Clin Trials Commun. 2025 Feb 15;44:101448. doi: 10.1016/j.conctc.2025.101448. eCollection 2025 Apr.
8
Immigrant status and citizenship relationships with epigenetic aging in a representative sample of United States adults.美国成年人代表性样本中移民身份和公民身份与表观遗传衰老的关系。
Epigenomics. 2025 Apr;17(5):309-316. doi: 10.1080/17501911.2025.2476378. Epub 2025 Mar 11.
9
Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society.巴西2型糖尿病筛查与诊断指南:巴西糖尿病协会的立场声明
Diabetol Metab Syndr. 2025 Mar 4;17(1):78. doi: 10.1186/s13098-024-01572-w.
10
Diabetes-Mediated STEAP4 Enhances Retinal Oxidative Stress and Impacts the Development of Diabetic Retinopathy.糖尿病介导的STEAP4增强视网膜氧化应激并影响糖尿病视网膜病变的发展。
Antioxidants (Basel). 2025 Feb 11;14(2):205. doi: 10.3390/antiox14020205.
在坎地沙坦治疗心力衰竭降低死亡率和发病率评估(CHARM)项目中慢性心力衰竭患者发生糖尿病的预测因素。
Diabetes Care. 2009 May;32(5):915-20. doi: 10.2337/dc08-1709. Epub 2009 Feb 5.
4
Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study.空腹血糖与糖化血红蛋白联合检测对2型糖尿病具有有效的预测作用:关西医疗保健研究
Diabetes Care. 2009 Apr;32(4):644-6. doi: 10.2337/dc08-1631. Epub 2009 Jan 8.
5
Translating the A1C assay into estimated average glucose values.将糖化血红蛋白检测结果转化为估计的平均血糖值。
Diabetes Care. 2008 Aug;31(8):1473-8. doi: 10.2337/dc08-0545. Epub 2008 Jun 7.
6
The prevention of type 2 diabetes.2型糖尿病的预防。
Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. doi: 10.1038/ncpendmet0843. Epub 2008 May 20.
7
Hemoglobin A1c can be helpful in predicting progression to diabetes after Whipple procedure.糖化血红蛋白 A1c 有助于预测 Whipple 手术后糖尿病的进展。
HPB (Oxford). 2007;9(1):26-8. doi: 10.1080/13651820600917286.
8
Relationship between glycated haemoglobin levels and mean glucose levels over time.糖化血红蛋白水平与平均血糖水平随时间的关系。
Diabetologia. 2007 Nov;50(11):2239-44. doi: 10.1007/s00125-007-0803-0. Epub 2007 Sep 13.
9
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.糖化血红蛋白可预测非糖尿病女性患糖尿病的风险,但不能预测其患心血管疾病的风险。
Am J Med. 2007 Aug;120(8):720-7. doi: 10.1016/j.amjmed.2007.03.022.
10
Short-term variability in measures of glycemia and implications for the classification of diabetes.血糖测量的短期变异性及其对糖尿病分类的影响。
Arch Intern Med. 2007 Jul 23;167(14):1545-51. doi: 10.1001/archinte.167.14.1545.